377 related articles for article (PubMed ID: 28383060)
1. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
[TBL] [Abstract][Full Text] [Related]
2. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
Jin SL; Lan L; Zoudilova M; Conti M
J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.
Huang H; Hong Q; Tan HL; Xiao CR; Gao Y
Acta Pharmacol Sin; 2016 Dec; 37(12):1543-1554. PubMed ID: 27665850
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.
Avila DV; Myers SA; Zhang J; Kharebava G; McClain CJ; Kim HY; Whittemore SR; Gobejishvili L; Barve S
Neuropharmacology; 2017 Oct; 125():376-385. PubMed ID: 28807677
[TBL] [Abstract][Full Text] [Related]
5. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.
Jin SL; Conti M
Proc Natl Acad Sci U S A; 2002 May; 99(11):7628-33. PubMed ID: 12032334
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of phosphodiesterase 4 inhibitor and serum on migration of endotoxin-stimulated macrophages.
Yang JX; Hsiung TC; Weng FC; Ding SL; Wu CP; Conti M; Chuang TH; Catherine Jin SL
Innate Immun; 2018 Nov; 24(8):501-512. PubMed ID: 30409089
[TBL] [Abstract][Full Text] [Related]
7. Evidence for reprogramming of monocytes into reparative alveolar macrophages in vivo by targeting PDE4b.
Rochford I; Joshi JC; Rayees S; Anwar M; Akhter MZ; Yalagala L; Banerjee S; Mehta D
Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L686-L702. PubMed ID: 34318714
[TBL] [Abstract][Full Text] [Related]
8. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
Li H; Li J; Zhang X; Feng C; Fan C; Yang X; Zhang R; Zhu F; Zhou Y; Xu Y; Liu H; Tang W
Biochem Pharmacol; 2020 Jul; 177():113958. PubMed ID: 32251674
[TBL] [Abstract][Full Text] [Related]
9. The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.
Avni D; Philosoph A; Meijler MM; Zor T
Immunology; 2010 Mar; 129(3):375-85. PubMed ID: 19922425
[TBL] [Abstract][Full Text] [Related]
10. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
MacKenzie SJ; Houslay MD
Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
Kuroiwa M; Snyder GL; Shuto T; Fukuda A; Yanagawa Y; Benavides DR; Nairn AC; Bibb JA; Greengard P; Nishi A
Psychopharmacology (Berl); 2012 Feb; 219(4):1065-79. PubMed ID: 21833500
[TBL] [Abstract][Full Text] [Related]
12. Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.
Guo J; Lin P; Zhao X; Zhang J; Wei X; Wang Q; Wang C
Neuroscience; 2014 Mar; 263():1-14. PubMed ID: 24434771
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.
Ma D; Wu P; Egan RW; Billah MM; Wang P
Mol Pharmacol; 1999 Jan; 55(1):50-7. PubMed ID: 9882697
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
[TBL] [Abstract][Full Text] [Related]
16. Amlexanox exerts anti-inflammatory actions by targeting phosphodiesterase 4B in lipopolysaccharide-activated macrophages.
Han Y; Hou R; Zhang X; Liu H; Gao Y; Li X; Qi R; Cai R; Qi Y
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118766. PubMed ID: 32504661
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
18. Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-
Zou ZQ; Chen JJ; Feng HF; Cheng YF; Wang HT; Zhou ZZ; Guo HB; Zheng W; Xu JP
J Pharmacol Exp Ther; 2017 Jul; 362(1):67-77. PubMed ID: 28450469
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
20. S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway.
Gobejishvili L; Avila DV; Barker DF; Ghare S; Henderson D; Brock GN; Kirpich IA; Joshi-Barve S; Mokshagundam SP; McClain CJ; Barve S
J Pharmacol Exp Ther; 2011 May; 337(2):433-43. PubMed ID: 21266552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
